Literature DB >> 26478238

Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia.

Ashraf A Sabe1, Brittany A Potz1, Nassrene Y Elmadhun1, Yuhong Liu1, Jun Feng1, M Ruhul Abid1, Jinnette D Abbott1, Donald R Senger2, Frank W Sellke3.   

Abstract

PURPOSE: Calpain overexpression is implicated in aberrant angiogenesis. We hypothesized that calpain inhibition (MDL28170) would improve collateral perfusion in a swine model with hypercholesterolemia and chronic myocardial ischemia.
METHODS: Yorkshire swine fed a high cholesterol diet for 4 weeks underwent surgical placement of an ameroid constrictor to their left circumflex coronary artery. Three weeks later, animals received no drug, high cholesterol control group (n = 8); low-dose calpain inhibition (0.12 mg/kg; n = 9); or high-dose calpain inhibition (0.25 mg/kg; n = 8). The heart was harvested after 5 weeks.
RESULTS: Myocardial perfusion in ischemic myocardium significantly improved with high-dose calpain inhibition at rest and with demand pacing (P = .016 and .011). Endothelium-dependent microvessel relaxation was significantly improved with low-dose calpain inhibition (P = .001). There was a significant increase in capillary density, with low-dose calpain inhibition and high-dose calpain inhibition (P = .01 and .01), and arteriolar density with low-dose calpain inhibition (P = .001). Calpain inhibition significantly increased several proangiogenic proteins, including vascular endothelial growth factor (P = .02), vascular endothelial growth factor receptor 1 (P = .003), vascular endothelial growth factor receptor 2 (P = .003), and talin, a microvascular structural protein (P = .0002). There was a slight increase in proteins implicated in endothelial-dependent (nitric oxide mediated) relaxation, including extracellular signal-regulated kinase, phosphorylated extracellular signal-regulated kinase, and inducible nitric oxide synthase with calpain inhibition.
CONCLUSIONS: In the setting of hypercholesterolemia, calpain inhibition improved perfusion, with a trend toward increased collateralization on angiography and increased capillary and arteriolar densities in ischemic myocardium. Calpain inhibition also improved endothelium-dependent microvessel relaxation and increased expression of proteins implicated in angiogenesis and vasodilatation.
Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  angiogenesis; animal model surgery; calpain inhibition; collateral circulation; ischemic heart disease; myocardial revascularization; perfusion

Mesh:

Substances:

Year:  2015        PMID: 26478238      PMCID: PMC4690774          DOI: 10.1016/j.jtcvs.2015.08.101

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  22 in total

1.  Role of calpain in hypoxic inhibition of nitric oxide synthase activity in pulmonary endothelial cells.

Authors:  Y Su; E R Block
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-06       Impact factor: 5.464

2.  Calpain-mediated proteolysis of talin regulates adhesion dynamics.

Authors:  Santos J Franco; Mary A Rodgers; Benjamin J Perrin; Jaewon Han; David A Bennin; David R Critchley; Anna Huttenlocher
Journal:  Nat Cell Biol       Date:  2004-09-19       Impact factor: 28.824

3.  Atorvastatin increases oxidative stress and modulates angiogenesis in Ossabaw swine with the metabolic syndrome.

Authors:  Nassrene Y Elmadhun; Antonio D Lassaletta; Louis M Chu; Yuhong Liu; Jun Feng; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2012-09-17       Impact factor: 5.209

4.  The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease.

Authors:  G M Lawrie; G C Morris; A Silvers; W F Wagner; A E Baron; S S Beltangady; D H Glaeser; D W Chapman
Journal:  Circulation       Date:  1982-10       Impact factor: 29.690

Review 5.  Therapeutic neovascularization for coronary disease: current state and future prospects.

Authors:  Antonio D Lassaletta; Louis M Chu; Frank W Sellke
Journal:  Basic Res Cardiol       Date:  2011-06-29       Impact factor: 17.165

6.  Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock.

Authors:  M C McDonald; H Mota-Filipe; A Paul; S Cuzzocrea; M Abdelrahman; S Harwood; R Plevin; P K Chatterjee; M M Yaqoob; C Thiemermann
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

7.  Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects.

Authors:  K P Rentrop; M Cohen; H Blanke; R A Phillips
Journal:  J Am Coll Cardiol       Date:  1985-03       Impact factor: 24.094

8.  A novel role for calpains in the endothelial dysfunction of hyperglycemia.

Authors:  Timothy J Stalker; Christopher B Skvarka; Rosario Scalia
Journal:  FASEB J       Date:  2003-06-03       Impact factor: 5.191

9.  Differential effects of atorvastatin on autophagy in ischemic and nonischemic myocardium in Ossabaw swine with metabolic syndrome.

Authors:  Ashraf A Sabe; Nassrene Y Elmadhun; Ahmed A Sadek; Louis M Chu; Cesario Bianchi; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2014-08-13       Impact factor: 5.209

10.  Calpain inhibition preserves talin and attenuates right heart failure in acute pulmonary hypertension.

Authors:  Hasan A Ahmad; Li Lu; Shuyu Ye; Gregory G Schwartz; Clifford R Greyson
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-10       Impact factor: 6.914

View more
  15 in total

Review 1.  Mechanisms of I/R-Induced Endothelium-Dependent Vasodilator Dysfunction.

Authors:  Ronald J Korthuis
Journal:  Adv Pharmacol       Date:  2017-12-08

Review 2.  Calpains and Coronary Vascular Disease.

Authors:  Brittany A Potz; Ashraf A Sabe; M Ruhul Abid; Frank W Sellke
Journal:  Circ J       Date:  2015-10-21       Impact factor: 2.993

3.  Diabetes and Cardioplegia.

Authors:  Brittany A Potz; Laura A Scrimgeour; Jun Feng; Frank W Sellke
Journal:  J Nat Sci       Date:  2017-06

4.  Role of Calpain in Pathogenesis of Human Disease Processes.

Authors:  Brittany A Potz; M Ruhul Abid; Frank W Sellke
Journal:  J Nat Sci       Date:  2016

5.  Calpain inhibition modulates glycogen synthase kinase 3β pathways in ischemic myocardium: A proteomic and mechanistic analysis.

Authors:  Brittany A Potz; Ashraf A Sabe; Nassrene Y Elmadhun; Richard T Clements; M Ruhul Abid; Neel R Sodha; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2016-11-16       Impact factor: 5.209

6.  Enhanced coronary arteriolar contraction to vasopressin in patients with diabetes after cardiac surgery.

Authors:  Nicholas Sellke; Alex Kuczmarski; Isabella Lawandy; Victoria L Cole; Afshin Ehsan; Arun K Singh; Yuhong Liu; Frank W Sellke; Jun Feng
Journal:  J Thorac Cardiovasc Surg       Date:  2018-06-08       Impact factor: 5.209

7.  Calpain inhibition decreases inflammatory protein expression in vessel walls in a model of chronic myocardial ischemia.

Authors:  Brittany A Potz; Ashraf A Sabe; Nassrene Y Elmadhun; Sharif A Sabe; Benedikt J V Braun; Richard T Clements; Anny Usheva; Frank W Sellke
Journal:  Surgery       Date:  2016-12-23       Impact factor: 3.982

Review 8.  Novel molecular targets for coronary angiogenesis and ischemic heart disease.

Authors:  Brittany A Potz; Anshul B Parulkar; Ruhul M Abid; Neel R Sodha; Frank W Sellke
Journal:  Coron Artery Dis       Date:  2017-11       Impact factor: 1.439

Review 9.  Coronary microvascular adaptations distal to epicardial artery stenosis.

Authors:  Daphne Merkus; Judy Muller-Delp; Cristine L Heaps
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-05-07       Impact factor: 5.125

10.  Calpain inhibition decreases myocardial fibrosis in chronically ischemic hypercholesterolemic swine.

Authors:  Brittany A Potz; Ashraf A Sabe; Sharif A Sabe; Isabella J Lawandy; M Ruhul Abid; Richard T Clements; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2020-03-29       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.